Allergan CEO says company is "weeks away" from closing Teva deal
May 23, 2016 at 12:22 PM EDT
May 23 (Reuters) - Allergan Inc Chief Executive Brent Saunders said on Monday the company expects to close the $40.5 billion sale of its generic medicines portfolio to Teva Pharmaceutical Industries Ltd in a matter of weeks, opening the door for new acquisitions.